SCHEMBL7114331

SCHEMBL7114331

O=S(=O)(C=Cc1ccc(Cl)cc1)Nc1ccc(OC2CCN(c3ccncc3)CC2)cc1

nearest known ligand 0.51

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
F10 P00742 3/20 0.51
ALDH1A1 P00352 2/20 0.45
ALOX15 P16050 1/20 0.45
TSHR P16473 1/20 0.45
CYP17A1 P05093 1/20 0.40
CYP21A2 P08686 1/20 0.40
CYP11B1 P15538 1/20 0.40
TRPV1 Q8NER1 1/20 0.40
LMNA P02545 1/20 0.39
PTPN1 P18031 1/20 0.39
ACACB O00763 2/20 0.38
NAMPT P43490 1/20 0.37
FPR2 P25090 4/20 0.37
PROKR1 Q8TCW9 4/20 0.37
GPR6 P46095 1/20 0.37
CYP2C9 P11712 1/20 0.37
EPHX2 P34913 1/20 0.37
CYP2J2 P51589 1/20 0.37
FFAR1 O14842 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7114329 1.00 F10 (0.51) F10ALDH1A1ALOX15TSHRCYP17A1
SCHEMBL5633166 0.90 ALDH1A1 (0.57) F10ALDH1A1ALOX15TSHRLMNA
SCHEMBL5633167 0.90 ALDH1A1 (0.57) F10ALDH1A1ALOX15TSHRLMNA
SCHEMBL5633181 0.89 F10 (0.48) F10ALDH1A1ALOX15TSHRCYP17A1
SCHEMBL5633179 0.89 F10 (0.48) F10ALDH1A1ALOX15TSHRCYP17A1
SCHEMBL7113722 0.86 F10 (0.55) F10ALDH1A1ALOX15TSHRCYP17A1
SCHEMBL7113715 0.86 F10 (0.55) F10ALDH1A1ALOX15TSHRCYP17A1
SCHEMBL7115318 0.81 F10 (0.44) F10CYP17A1CYP21A2CYP11B1PTPN1
SCHEMBL7115313 0.81 F10 (0.44) F10CYP17A1CYP21A2CYP11B1PTPN1
SCHEMBL5632002 0.80 ALDH1A1 (0.49) F10ALDH1A1ALOX15TSHRLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030207882-A1 Aminoheterocyclic derivatives as antithrombotic or anticoagulant agents ZENECA LIMITED 2003-11-06 US claimed
US-20030207882-A1 Aminoheterocyclic derivatives as antithrombotic or anticoagulant agents ZENECA LIMITED 2003-11-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030207882-A1 Aminoheterocyclic derivatives as antithrombotic or anticoagulant agents F2, SERPINC1, F11 F10 8/4885ALDH1A1 753/4885ALOX15 1252/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.